Subscribe to our newsletter to receive the latest product updates and special offers

HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite
Theme 		Help
Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#71 / 200 Total
AIRI - Air Industries Group - Stock Price Chart
TickerAIRI [AMEX]
CompanyAir Industries Group
CountryUSA
IndustryAerospace & Defense
Market Cap21.58MEPS (ttm)-0.65
P/E-EPS this Y55.38%
Forward P/E-EPS next Y44.83%
PEG-EPS past 5Y30.33%
P/S0.42EPS next 5Y-
P/B1.41EPS Q/Q119.80%
Dividend-Sales Q/Q-3.03%
Insider Own26.07%Inst Own6.96%
Insider Trans0.00%Inst Trans-1.30%
Short Float0.39%EarningsApr 01/a
Analyst Recom1.00Target Price7.50
Avg Volume33.64K52W Range2.60 - 7.77
Apr-01-24 04:00PM Air Industries Group Reports Preliminary Fourth Quarter and Full-Year 2023 Financial Results and Initial 2024 Business Outlook (Business Wire)
Mar-27-24 05:06PM Air Industries Group To Preliminary Report Q4 and FY 2023 Results on April 1, 2024 and Schedules Earnings Conference Call (Business Wire)
Jan-23-24 08:30AM Air Industries Group Receives Two Strategically Important New Contracts from New Customers (Business Wire)
Jan-03-24 08:30AM Air Industries Group Subsidiary Sterling Engineering Corporation Receives $3.2M in New Contracts (Business Wire)
Dec-06-23 04:30PM Air Industries Group Announces Results for Third Quarter Ended September 30, 2023 and Comments on Business Outlook (Business Wire) +5.88%
Nov-29-23 04:30PM Air Industries Group Receives Notice from NYSE American Regarding Late Filing of Quarterly Report on Form 10-Q (Business Wire)
Oct-19-23 08:30AM Air Industries Group Announces CFO Transition (Business Wire)
Sep-08-23 08:30AM Air Industries Group Adds Important Arresting Gear Welding Capability to Support U.S. Navy E-2D Aircraft Program (Business Wire)
Aug-08-23 08:30AM Air Industries Group Announces Improved Operating Results for Second Quarter Ended June 30, 2023 and Provides Comments on Business Outlook (Business Wire)
Jul-12-23 08:30AM Air Industries Group Announces the Appointment of Peter Rettaliata as Chairman of the Board (Business Wire)
BLFS - Biolife Solutions Inc - Stock Price Chart
TickerBLFS [NASD, RUT]
CompanyBiolife Solutions Inc
CountryUSA
IndustryMedical Instruments & Supplies
Market Cap894.80MEPS (ttm)-1.43
P/E-EPS this Y53.85%
Forward P/E-EPS next Y40.20%
PEG-EPS past 5Y0.51%
P/S6.52EPS next 5Y10.00%
P/B2.64EPS Q/Q29.40%
Dividend-Sales Q/Q-15.85%
Insider Own4.71%Inst Own100.96%
Insider Trans-4.11%Inst Trans5.04%
Short Float8.24%EarningsMay 09/a
Analyst Recom1.25Target Price22.86
Avg Volume402.11K52W Range8.92 - 24.50
Today 12:37PM BioLife Solutions, Inc. (NASDAQ:BLFS) Q1 2024 Earnings Call Transcript (Insider Monkey) +9.68%
May-09-24 10:57PM BLFS Stock Earnings: BioLife Solns Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace)
06:05PM BioLife Solutions, Inc. (BLFS) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:03PM BioLife Solutions Reports First Quarter 2024 Financial Results (PR Newswire)
May-02-24 10:01AM BioLife Solutions, Inc. (BLFS) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release (Zacks)
Apr-30-24 04:12PM BioLife Solutions to Report First Quarter 2024 Financial Results and Business Update on May 9, 2024 (PR Newswire)
Apr-18-24 11:00AM Insider Sell: Chief Marketing Officer Todd Berard Sells 10,000 Shares of BioLife Solutions Inc ... (GuruFocus.com)
08:05AM BioLife Solutions Announces the Divestiture of its Stirling Freezer Business (PR Newswire)
Mar-27-24 04:37PM Corporate Insiders Are Selling These 10 Small-Cap Stocks (Insider Monkey)
Mar-14-24 02:15AM Director Amy Duross Sells 11,200 Shares of BioLife Solutions Inc (BLFS) (GuruFocus.com)
TC - TuanChe Ltd ADR - Stock Price Chart
TickerTC [NASD]
CompanyTuanChe Ltd ADR
CountryChina
IndustryInternet Content & Information
Market Cap3.39MEPS (ttm)-
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y27.32%
P/S-EPS next 5Y-
P/B-EPS Q/Q-72.85%
Dividend-Sales Q/Q-48.02%
Insider Own11.46%Inst Own15.18%
Insider Trans0.00%Inst Trans-99.15%
Short Float1.66%Earnings-
Analyst Recom-Target Price-
Avg Volume65.62K52W Range1.40 - 11.25
May-09-24 07:29AM Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday (InvestorPlace)
Mar-28-24 05:30PM TuanChe Files Its Annual Report on Form 20-F (PR Newswire)
Feb-12-24 06:00AM TuanChe Has Regained Compliance with Nasdaq's Minimum Bid Price Requirement (PR Newswire)
Jan-24-24 10:50AM /C O R R E C T I O N -- TuanChe Limited/ (PR Newswire)
Jan-23-24 05:00PM TuanChe Announces Plan to Implement ADS Ratio Change (PR Newswire) -12.52%
Nov-22-23 06:00AM TuanChe Limited Announces Results of Annual General Meeting of Shareholders (PR Newswire) -14.99%
Oct-18-23 07:00AM TuanChe to Hold 2023 Annual General Meeting on November 22, 2023 (PR Newswire) -10.28%
Sep-28-23 05:00PM TuanChe Announces Unaudited First Half 2023 Financial Results (PR Newswire) -7.32%
Aug-21-23 07:00AM TuanChe Limited Receives Second Compliance Period Granted by Nasdaq (PR Newswire) -5.73%
Jul-14-23 09:05AM Benign Growth For TuanChe Limited (NASDAQ:TC) Underpins Its Share Price (Simply Wall St.)
IMMX - Immix Biopharma Inc - Stock Price Chart
TickerIMMX [NASD]
CompanyImmix Biopharma Inc
CountryUSA
IndustryBiotechnology
Market Cap53.46MEPS (ttm)-0.90
P/E-EPS this Y-24.00%
Forward P/E-EPS next Y-8.60%
PEG-EPS past 5Y-63.30%
P/S-EPS next 5Y-
P/B2.46EPS Q/Q11.04%
Dividend-Sales Q/Q-
Insider Own47.54%Inst Own8.93%
Insider Trans0.45%Inst Trans19.81%
Short Float2.80%Earnings-
Analyst Recom1.00Target Price14.00
Avg Volume186.59K52W Range1.40 - 7.75
Today 09:35AM Immix Biopharma Announces Positive NXC-201 Relapsed/Refractory AL Amyloidosis Clinical Data in ASGCT 2024 Late Breaking Oral Presentation (GlobeNewswire) -7.11%
Apr-29-24 02:50PM Immix Biopharma Gets Orphan Drug Label in Europe For Multiple Myeloma Treatment (MT Newswires)
09:39AM Immix Biopharma Awarded European Union Orphan Drug Designation for NXC-201 in Multiple Myeloma (GlobeNewswire)
Apr-18-24 09:37AM Nexcella, an Immix Biopharma Subsidiary, on Track to Dose NXC-201 Patients in United States (GlobeNewswire) -11.60%
09:32AM Immix Biopharma on Track to Dose NXC-201 Patients in United States (GlobeNewswire)
Apr-15-24 09:36AM Immix Biopharma Announces Late-Breaking NXC-201 Clinical Data Abstract Accepted for Oral Presentation at the 27th Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT) (GlobeNewswire)
Apr-02-24 07:53AM IMMX Stock Earnings: Immix Biopharma Misses EPS for Q4 2023 (InvestorPlace)
Mar-20-24 09:46AM Immix Biopharma Announces Major Comprehensive Cancer Center as Lead Site for NXC-201 AL Amyloidosis Clinical Trial (GlobeNewswire)
Mar-05-24 09:35AM Immix Biopharma Announces Be Proactive in AL AL Amyloidosis Awareness Initiative (GlobeNewswire) -8.06%
Feb-21-24 09:31AM Immix Biopharma 12 Month Review Progress Update (GlobeNewswire)
CHR - Cheer Holding Inc - Stock Price Chart
TickerCHR [NASD]
CompanyCheer Holding Inc
CountryChina
IndustryAdvertising Agencies
Market Cap28.34MEPS (ttm)3.32
P/E0.85EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y46.85%
P/S0.19EPS next 5Y-
P/B0.10EPS Q/Q339.36%
Dividend-Sales Q/Q-
Insider Own26.13%Inst Own9.02%
Insider Trans0.00%Inst Trans-
Short Float0.32%EarningsMar 14/b
Analyst Recom1.00Target Price75.00
Avg Volume23.48K52W Range2.18 - 6.76
May-07-24 06:30AM Cheer Holding's Subsidiary Obtained Recognition as Specialized and Innovative Enterprise in Beijing (GlobeNewswire)
Apr-23-24 06:30AM Cheer Holding Subsidiary Recognized as Innovative SME by Beijing Municipal Government (GlobeNewswire)
Apr-09-24 06:30AM Cheer Holding Unveils Captivating Original AI Animation 'Wasteland' (GlobeNewswire)
Apr-02-24 06:30AM Cheer Holding Secures National Patent for Groundbreaking NFT Trading Method and System (GlobeNewswire)
Mar-26-24 06:30AM Cheer Holding Releases AI Animated Miniseries 'Mystical Realm of Mountains and Seas' (GlobeNewswire)
Mar-14-24 08:05AM Cheer Holding Reports Full Year 2023 Financial Results (GlobeNewswire) +18.11%
Feb-20-24 07:00AM CHEERS Telepathy Unveils Year of the Dragon Edition, Elevating AI-Powered Content Marketing to New Heights (GlobeNewswire) -6.34%
Feb-06-24 07:30AM Cheer Holding Secures National Invention Patent for Revolutionary AI Core Technology (GlobeNewswire)
06:30AM Cheer Holding's Subsidiary Recognized Once Again as National High-Tech Enterprise, Boosting Business Prospects (GlobeNewswire)
Dec-19-23 08:00AM CHEERS Video Announces Product Upgrade and Rebrands as CHEERS Lifestyle Architect (PR Newswire)
FATE - Fate Therapeutics Inc - Stock Price Chart
TickerFATE [NASD, RUT]
CompanyFate Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap466.66MEPS (ttm)-1.92
P/E-EPS this Y-17.30%
Forward P/E-EPS next Y5.91%
PEG-EPS past 5Y-6.65%
P/S72.02EPS next 5Y-
P/B1.09EPS Q/Q-146.52%
Dividend-Sales Q/Q-96.74%
Insider Own12.24%Inst Own83.47%
Insider Trans-0.25%Inst Trans-2.76%
Short Float22.17%EarningsMay 09/a
Analyst Recom2.56Target Price6.93
Avg Volume2.60M52W Range1.63 - 8.83
Today 10:36AM Piper Sandler Adjusts Fate Therapeutics' Price Target to $4 From $7, Keeps Neutral Rating (MT Newswires) +5.13%
08:22AM Wedbush Adjusts Fate Therapeutics' Price Target to $5 From $7, Keeps Neutral Rating (MT Newswires)
May-09-24 08:58PM FATE Stock Earnings: Fate Therapeutics Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace) +5.41%
05:25PM Fate Therapeutics (FATE) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:21PM Fate Therapeutics: Q1 Earnings Snapshot (Associated Press Finance)
04:01PM Fate Therapeutics Reports First Quarter 2024 Financial Results and Business Updates (GlobeNewswire)
08:30AM Fate Therapeutics Announces First Lupus Patient Treated in Phase 1 Autoimmunity Study of Off-the-shelf FT819 CAR T-cell Program (GlobeNewswire)
May-06-24 08:00AM Fate Therapeutics to Webcast Conference Call Reporting First Quarter 2024 Financial Results and Operational Updates (GlobeNewswire)
May-03-24 04:30PM Fate Therapeutics Announces Presentation of FT522 Preclinical Data for Autoimmune Diseases in Late-breaking Abstract at ASGCT Annual Meeting (GlobeNewswire)
Apr-22-24 04:30PM Fate Therapeutics Announces Presentation of FT819 Proof-of-Concept Data for B cell-mediated Autoimmune Diseases at ASGCT Annual Meeting (GlobeNewswire)
PDSB - PDS Biotechnology Corporation - Stock Price Chart
TickerPDSB [NASD, RUT]
CompanyPDS Biotechnology Corporation
CountryUSA
IndustryBiotechnology
Market Cap127.83MEPS (ttm)-1.39
P/E-EPS this Y-8.75%
Forward P/E-EPS next Y-6.77%
PEG-EPS past 5Y42.97%
P/S-EPS next 5Y-
P/B4.41EPS Q/Q48.28%
Dividend-Sales Q/Q-
Insider Own4.89%Inst Own22.12%
Insider Trans0.00%Inst Trans-2.52%
Short Float19.67%EarningsMay 15/b
Analyst Recom1.00Target Price15.00
Avg Volume945.81K52W Range2.59 - 10.27
Today 05:49AM PDS Biotechnology Says Head, Neck Cancer Therapy Met Main Goal in Mid-Stage Study (MT Newswires) -9.01%
May-09-24 05:46PM PDS Biotech VERSATILE-002 Phase 2 Clinical Trial Meets Primary Study Endpoints in First Line Recurrent/Metastatic HPV16-Positive Head and Neck Cancer (GlobeNewswire)
08:00AM PDS Biotech to Participate in Upcoming May 2024 Investor Conferences (GlobeNewswire)
May-07-24 08:00AM PDS Biotech to Announce First Quarter 2024 Financial Results on May 15, 2024 (GlobeNewswire)
May-03-24 08:00AM PDS Biotechnology Announces Details of Virtual KOL Event (GlobeNewswire)
May-02-24 08:00AM PDS Biotech Appoints Stephan Toutain as Chief Operating Officer (GlobeNewswire)
Apr-23-24 08:00AM PDS Biotech to Host Key Opinion Leader Event to Discuss Positive, Updated Data from Phase 2 VERSATILE-002 Clinical Trial with Versamune HPV in Combination with KEYTRUDA in Recurrent or Metastatic Head and Neck Cancer (GlobeNewswire) +7.02%
Mar-28-24 10:24AM PDS Biotechnology Corporation (NASDAQ:PDSB) Q4 2023 Earnings Call Transcript (Insider Monkey)
Mar-27-24 11:33PM Q4 2023 PDS Biotechnology Corp Earnings Call (Thomson Reuters StreetEvents) -14.06%
11:52AM PDSB Stock Earnings: PDS Biotechnology Beats EPS for Q4 2023 (InvestorPlace)
BZFD - BuzzFeed Inc - Stock Price Chart
TickerBZFD [NASD]
CompanyBuzzFeed Inc
CountryUSA
IndustryInternet Content & Information
Market Cap84.34MEPS (ttm)-0.85
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S0.29EPS next 5Y47.50%
P/B0.70EPS Q/Q89.96%
Dividend-Sales Q/Q-43.80%
Insider Own13.50%Inst Own8.55%
Insider Trans-2.23%Inst Trans2.82%
Short Float3.22%EarningsMay 13/a
Analyst Recom3.00Target Price4.00
Avg Volume1.29M52W Range0.64 - 3.20
May-02-24 11:30AM BuzzFeed, Inc. Announces 1-For-4 Reverse Stock Split (Business Wire)
Apr-22-24 04:30PM BuzzFeed, Inc. to Release First Quarter 2024 Financial Results on Monday, May 13, 2024 (Business Wire)
Apr-16-24 12:18PM A reverse stock split is BuzzFeed's last hope of staying listed on the Nasdaq (Quartz) -6.19%
10:58AM BZFD Stock: BuzzFeed Is Prepping for a Reverse Stock Split (InvestorPlace)
Mar-28-24 10:04AM The Independent and BuzzFeed Sign Long-Term License and Strategic Partnership in UK & Ireland (Business Wire) +17.01%
Mar-27-24 11:24AM BuzzFeed, Inc. (NASDAQ:BZFD) Q4 2023 Earnings Call Transcript (Insider Monkey)
Mar-26-24 12:50PM Stocks to Watch Tuesday: Trump Media, GameStop, BuzzFeed, Tesla (The Wall Street Journal)
Mar-25-24 09:52PM BZFD Stock Earnings: BuzzFeed Misses Revenue for Q4 2023 (InvestorPlace) +9.11%
04:32PM BuzzFeed, Inc. Makes Strategic & Organizational Changes to Improve Profitability After Challenging Q4 and Full Year 2023 (Business Wire)
12:53PM Stocks to Watch Monday: DWAC, AMD, Boeing (The Wall Street Journal)
DZSI - DZS Inc - Stock Price Chart
TickerDZSI [NASD, RUT]
CompanyDZS Inc
CountryUSA
IndustryCommunication Equipment
Market Cap53.64MEPS (ttm)-1.76
P/E-EPS this Y1.32%
Forward P/E33.40EPS next Y-87.01%
PEG-EPS past 5Y-
P/S0.14EPS next 5Y20.00%
P/B0.41EPS Q/Q-398.55%
Dividend-Sales Q/Q17.88%
Insider Own46.95%Inst Own23.83%
Insider Trans0.00%Inst Trans-
Short Float7.70%Earnings-
Analyst Recom1.00Target Price6.50
Avg Volume194.94K52W Range0.95 - 7.39
May-06-24 04:30PM DZS to Acquire Subscriber Access Technology Leader NetComm (GlobeNewswire) +19.25%
Apr-25-24 08:00AM DZS Appoints Scott St. John as Chief Customer Officer (GlobeNewswire)
Apr-24-24 08:00AM DZS Receives Favorable Nasdaq Listing Decision (GlobeNewswire) -5.83%
Apr-22-24 08:00AM DZS Appoints Brian Chesnut as Chief Accounting Officer (GlobeNewswire) +7.96%
Apr-08-24 08:55AM DZS (DZSI) Closes Asia Business Divestiture for Core Focus (Zacks)
Apr-05-24 08:00AM DZS Completes Divestiture of Asia Business (GlobeNewswire)
Mar-25-24 08:00AM The City of Cabot and Connect2First Bridge Digital Divide in Arkansas with Help from DZS and Irby (GlobeNewswire) +6.98%
Mar-22-24 09:14AM DZS (DZSI) & Infinera Team Up to Drive Optical Innovation (Zacks)
Mar-20-24 08:00AM DZS and Infinera to Demo Game-Changing ICE-X Coherent Pluggable Solutions for Mobile xHaul and Advanced Business Services at OFC (GlobeNewswire)
Mar-18-24 08:00AM DZS Further Transforms Economics of Optical Edge with Launch of Saber 2200 Coherent xHaul Ethernet Switch (GlobeNewswire) -7.75%
LTRN - Lantern Pharma Inc - Stock Price Chart
TickerLTRN [NASD]
CompanyLantern Pharma Inc
CountryUSA
IndustryBiotechnology
Market Cap64.41MEPS (ttm)-1.47
P/E-EPS this Y-45.12%
Forward P/E-EPS next Y10.94%
PEG-EPS past 5Y-39.81%
P/S-EPS next 5Y-
P/B1.57EPS Q/Q-24.47%
Dividend-Sales Q/Q-
Insider Own26.83%Inst Own10.78%
Insider Trans-19.44%Inst Trans0.92%
Short Float6.15%EarningsMay 09/a
Analyst Recom2.00Target Price22.00
Avg Volume341.74K52W Range2.38 - 11.99
May-09-24 04:02PM Lantern Pharma Reports First Quarter 2024 Financial Results and Business Highlights (Business Wire) +5.09%
May-06-24 06:41AM Lantern Pharma and Oregon partner to develop cancer treatment (Pharmaceutical Technology) +11.38%
04:37AM Lantern Pharma, Oregon Therapeutics Partner to Develop AI-Driven Cancer Drug Collaboration (MT Newswires)
03:00AM Oregon Therapeutics & Lantern Pharma Launch Strategic AI Collaboration to Optimize Development of First-In-Class Drug Candidate XCE853 A Potent Inhibitor of Cancer Metabolism (Business Wire)
May-02-24 07:30AM Lantern Pharma to Report First Quarter 2024 Operating & Financial Results on May 9th, 2024 at 4:30 p.m. ET (Business Wire)
May-01-24 06:00AM 3 Machine Learning Stocks with the Potential to Make You an Overnight Millionaire (InvestorPlace) +5.69%
Apr-24-24 08:00AM Lantern Pharma Launches "Webinar Wednesdays" Featuring World-Class Physician Scientists & Key Opinion Leaders Discussing Critical Areas of Oncology Drug Development (Business Wire) -6.76%
Apr-22-24 08:12AM Lantern Pharma Receives Regulatory Approval to Expand Harmonic Clinical Trial for Non-Small Cell Lung Cancer in Never-Smokers into Japan and Taiwan (Business Wire) +7.12%
Apr-10-24 08:45AM Software Segment of Global A.I. Healthcare Billion Dollar Market Expected to Have Fastest Growth (PR Newswire)
Mar-20-24 09:00AM Global A.I. Medical Diagnostics Market Poised To Reach $3.7 Billion By 2028 (GlobeNewswire) +17.49%
1⋯345678910111213⋯20
affiliate • advertise • toggle light mode • contact • privacy • help
do not sell my data • privacy settings
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2024 FINVIZ.com. All Rights Reserved.